glp-1 microneedle patch Anodyne picks up $12.6M to advance once-weekly glp 1 nano microneedle patch

No Cold Chain: Because they are chemically stable, they dont require the expensive refrigerated shipping and storage that injectables do

Obesity and metabolic disorders are on the rise globally

Learn how food affects absorption and effectiveness.

and in July 2024, the FDA approved Kisunla (donanemab) for early symptomatic Alzheimers, based on evidence of reduced clinical decline and a limitedduration regimen tied to amyloid plaque removal

However, GLP-1 RAs are also associated with emerging cutaneous adverse drug reactions, including bullous, exanthematous and vasculitic manifestations, and other rare side effects